News

Day One Announces Two New Appointments to Board of Directors

BRISBANE, Calif., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a clinical-stage…

2 years ago

Safety Shot Responds to FSD Pharma’s 3rd unauthorized Tagging of its Stock and Making False Claims in an Effort to Harm the Company and its Shareholders

Safety Shot is Not GBB Drink Lab, Inc. (GBB) and never acquired GBB as falsely claimed by FSD Pharma; Only…

2 years ago

Lisata Therapeutics Announces First Patient Treated in the Phase 2a Trial of LSTA1 in Patients with Glioblastoma Multiforme

BASKING RIDGE, N.J., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

2 years ago

Gamida Cell to Present at the 2024 Tandem Meetings of ASTCT® and CIBMTR®

BOSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells…

2 years ago

BioAdaptives Announces Signing of a New Distributor’s Agreement for AI Body Composition Measuring App and New Weight Management System

BioAdaptives, Inc. ASSESS BODY FAT CONTENT FROM ONE PICTURE The first-ever approach resulted from validating studies over a single lateral…

2 years ago

Aclarion Announces Updated Product Release That Expands MRI Scanner Access for Nociscan Solution

Nociscan is the first augmented intelligence platform to measure pain biomarkers in the lumbar spine This new product release expands…

2 years ago

Jack Ride 15 Brings Community Together to End the Youth Mental Health Emergency

Jack.org invites you to join Canada’s Ride for Youth Mental Health and support life-changing youth mental health programs in communities…

2 years ago

ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis

Up to 40% of women with triple negative breast cancer (TNBC) experience metastasis to their brain, which affects physical function,…

2 years ago

DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution

CERVAI™ Brain Health CERVAI™ Brain Health TORONTO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”)…

2 years ago